Chinese Innovative Drug Cipepofol Breaks into Global Market with U.S. FDA Approval
China's homegrown Class 1 innovative intravenous anesthetic, Cipepofol (CYPSEDO) Injection, developed by Haisco Pharmaceutical Group, has secured marketing approval from the U.S. Food and Drug Administration (FDA), marking a significant.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
